Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine and Inflammation in Aortic Stenosis
2021-005586-40Phase 3Active
- Sponsor
- Radboudumc
- Start
- Jan 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of colchicine in aortic stenosis (AS), sponsored by Radboudumc. Primary endpoint: Change in aortic valve calcium score. Started Jan 2022; status: active.
02
Drugs
colchicine
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2021-005586-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005586-40.